OMX30 1 499 0,7%  OMXH25 3 939 0,6%  Bitcoin 5 616,65 0,2%  Dow 25 413 0,5%  Nas 6 867 -0,3%  EUR 10,2842 0,0%  USD 9,0061 0,0%  Olja 67,1 0,7%  Guld 1 221 0,7% 

Danaher Aktie

103,24USD 1,57USD 1,54%
Relaterade värdepapper

Danaher Corp. - Profil

Danaher Corp. operates as a medical company, which designs, manufactures, and markets healthcare, environmental, and industrial equipment. It operates through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research and clinical tools that scientists use to study cells and cell components in order to understand the causes of diseases; identify new therapies; and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Dental segment develops products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums, and supporting bones; as well as provide dental consumables, equipment, and services. The Environmental & Applied Solution segment engages in the development and manufacture of equipment, consumables, and software for various printing, marking, coding, design, and color management applications for global and water supply industries. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.


Ägare i %
T. Rowe Price Associates, Inc.6,42
The Vanguard Group, Inc.5,97
BlackRock Fund Advisors4,09
SSgA Funds Management, Inc.3,52
Massachusetts Financial Services Co.3,07
Fidelity Management & Research Co.2,55
Wellington Management Co. LLP2,38
Northern Trust Investments, Inc.1,32
Norges Bank Investment Management0,99
Parnassus Investments0,97
Geode Capital Management LLC0,90
Brown Advisory LLC0,86
Flossbach von Storch AG0,80
Putnam Investment Management LLC0,80


2200 Pennsylvania Avenue NW, 20037-1701 Washington
Telefon: 12028280850
Fax: 12028280860


Matthew R. McGrew
CFO-Diagnostics & Dental platforms
Steven M. Rales
Robert S. Lutz
Chief Accounting Officer & Senior Vice President
Daniel L. Comas, MBA
Chief Financial Officer & Executive Vice President
Mitchell P. Rales
Joakim Weidemanis
Executive Vice President
William K. Daniel II, MBA
Executive Vice President
Rainer Blair
Executive Vice President
Alan G. Spoon
Independent Director
Linda Hefner Filler, MBA
Independent Director
Walter G. Lohr, Jr.
Independent Director
John T. Schwieters, CPA
Independent Director
Elias A. Zerhouni, MD
Independent Director
Raymond C. Stevens, PhD
Independent Director
Teri L. List-Stoll, CPA
Independent Director
Donald Jerry Ehrlich
Lead Independent Director
Thomas Patrick Joyce, Jr.
President, Chief Executive Officer & Director
James F. O'Reilly
Secretary & Vi, VP & Associate General Counsel
Brian W. Ellis
Senior Vice President & General Counsel
Daniel A. Raskas, MBA
Senior Vice President-Corporate Development
James H. Ditkoff
Senior Vice President-Finance & Tax
Angela S. Lalor
Senior Vice President-Human Resources
William H. King IV
Senior Vice President-Strategic Development
Manish Bhatnagar
Vice President & General Manager
Philip Bernard Whitehead
Vice President & MD-Europe Corporate Development
Matthew E. Gugino
Vice President-Investor Relations

Lägg till instrument